Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (Tdap) vaccine- related erythema nodosum: Case report and review of vaccine-associated erythema nodosum

Dermatology and Therapy

Volumn 3, Issue 2, 2013, Pages 191-197

  Cohen, Philip R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acellular pertussis; Dermatology; Diphtheria; Erythema nodosum; Tdap; Tetanus; Vaccination; Vaccine; Vaccine associated; Vaccinerelated

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; FEXOFENADINE; IBUPROFEN; PREDNISONE;

ADULT; ARTHUS PHENOMENON; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ERYTHEMA NODOSUM; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; JAPANESE (PEOPLE); LEG; MEDICAL HISTORY; PALLIATIVE THERAPY; PRIORITY JOURNAL; VACCINATION;

EID: 84898915907     PISSN: None     EISSN: 21909172     Source Type: Journal    
DOI: 10.1007/s13555-013-0035-9     Document Type: Article

References (24)

1. McCormack PL. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix): a review of its properties and use as a single-dose immunization. Drugs. 2012; 72:1765-91.
2. Plosker GL. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US. BioDrugs. 2009;23:253-67.
3. Clark TA, Bobo N. CDC update on pertussis surveillance and Tdap vaccine recommendations. NASN Sch Nurse. 2012;27:297-300.
4. Centers for Disease Control and Prevention. American Academy of Pediatrics Committee on Infectious Diseases: additional recommendations for use of tetanus toxoid, reduced-content diphtheria toxoid, and acellular pertussis vaccine (Tdap). Pediatrics. 2011;128:809-12.
5. Chang S, O'Connor PM, Slade BA, Woo EJ. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007. Vaccine. 2013;31:1447-52.
6. Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol. 2012; 207:59. e1-59. e7.
7. Moro PL, Yue X, Lewis P, Haber P, Broder K. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010. Vaccine. 2011;29:9404-8.
8. Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management. Dermatol Ther. 2010;23:320-7.
9. Requena L, Sanchez Yus E. Erythema nodosum. Dermatol Clin. 2008;26:425-38.
10. Mana J, Marcoval J. Erythema nodosum. Clin Dermatol. 2007;25:288-94.
11. Requena L, Sanchez Yus E. Erythema nodosum. Semin Cutan Med Surg. 2007;26:114-25.
12. Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007; 75:695-700.
13. Franco-Paredes C, Diaz-Borjon A, Senger MA, Barragan L, Leonard M. The ever-expanding association between rheumatologic diseases and tuberculosis. Am J Med. 2006;119:470-7.
14. Sota Busselo I, Onate Vergara E, Perez-Yarza EG, Lopez Palma F, Ruiz Benito A, Albisu Andrade Y. Erythema nodosum: etiological changes in the last two decades. An Pediatr (Barc). 2004;61:403-7.
15. Galzerano G, Sorrentini R. Case of erythema nodosum appearing after BCG vaccination. Arch Tisiol Mal Appar Respir. 1958;13:631-41.
16. Rogerson SJ, Nye FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Br Med J. 1990;301:345.
17. Goolsby PL. Erythema nodosum after Recombivax HB hepatitis B vaccine [letter]. N Engl J Med. 1989;321:1198-9.
18. Di Giusto CA, Bernhard JD. Erythema nodosum provoked by hepatitis B vaccine. Lancet. 1986; 2:1042.
19. Longueville C, Doffoel-Hantz V, Hantz S, Souyri N, Nouaille Y, Bedane C, Sparsa A. Gardasil-induced erythema nodosum. Rev Med Interne. 2012; 33:e17-8.
20. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS ONE. 2008;3:e2636.
21. Kaliyadan F, Dharmaratnam AM. Erythema nodosum-an association with rabies vaccination. Dermatol Online J. 2008;14:22.
22. Corcos A. Appearance of erythema nodosum at site of a dog-bite after vaccination against rabies. Bull Soc Pathol Exot Filiales. 1957;50:886-8.
23. Matheis H. Skin complications of smallpox vaccination. Dermatologica. 1971;142:340-3.
24. Thomson BJ, Nuki G. Erythema nodosum following typhoid vaccination. Scott Med J. 1985;30:173.